Abstract
AimTo identify the types of glaucoma and associated comorbidities among patients attending the ophthalmology clinic at King Abdulaziz Medical City (KAMC) in Jeddah.MethodsA cross-sectional study that included all glaucoma patients at KAMC in Jeddah between June 1st, 2016 and November 30th, 2020. Data were collected through retrospective chart review from the electronic medical record system (BestCare) and utilized a structured data collection sheet.ResultsA total of 283 patients met the inclusion criteria. The most common type was primary open-angle glaucoma (POAG; 53%) followed by secondary glaucomas (SG; 26.5%) then childhood glaucoma and primary angle-closure glaucoma (CG, PACG; 7.4%). The majority of secondary glaucoma cases were due to neovascular glaucoma (NVG; 44.9%), followed by phacomorphic glaucoma (17.9%) and phacolytic glaucoma (10.3%). Hypertension (60.8%) and diabetes (58.3%) were the most prevalent systematic comorbidities, and cataract (49.1%) was the most prevalent ocular comorbidity.ConclusionPOAG was the most common glaucoma type, followed by SG, CG, and PACG. Among secondary glaucoma types, neovascular glaucoma was found to be the most common subtype. Hypertension was the most prevalent comorbid condition.
Highlights
Blindness is one of the major public health concerns, and as the size of the population increases, this issue will exert a huge burden on public health [1]
The majority of secondary glaucoma cases were due to neovascular glaucoma (NVG; 44.9%), followed by phacomorphic glaucoma (17.9%) and phacolytic glaucoma (10.3%)
Projections for the worldwide burden of glaucoma have estimated that glaucoma prevalence will rise by 74% from 2013 to 2040, which accounts for 111.8 million patients, most of whom are in Asia and Africa [6]
Summary
Blindness is one of the major public health concerns, and as the size of the population increases, this issue will exert a huge burden on public health [1]. Glaucoma is a group of eye diseases that can result in irreversible visual field loss and degenerative optic neuropathy. It is asymptomatic at early stages, but permanent visual impairment can ensue at late stages [2]. It is estimated that the pooled worldwide prevalence of glaucoma between the ages of 40-80 is 3.54% [6]. Projections for the worldwide burden of glaucoma have estimated that glaucoma prevalence will rise by 74% from 2013 to 2040, which accounts for 111.8 million patients, most of whom are in Asia and Africa [6]. The latest estimate on the prevalence of glaucoma in Saudi Arabia is 5.6%, based on a 2019 study in Riyadh governorate which involved 940 subjects across six
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
